CDMO - Avid Bioservices Inc. (CDMO) Q3 2024 Earnings Call Transcript
2024-04-29 21:39:02 ET
Avid Bioservices, Inc. (CDMO)
Q3 2024 Earnings Conference Call
April 29, 2024 4:30 PM ET
Company Participants
Tim Brons – Investors Relations Group
Nick Green – President and Chief Executive Officer
Dan Hart – Chief Financial Officer
Matt Kwietniak – Chief Commercial Officer
Conference Call Participants
Jacob Johnson – Stephens
Sean Dodge – RBC Capital Markets
Matt Hewitt – Craig-Hallum Capital Group
Max Smock – William Blair
Paul Knight – KeyBanc
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Avid Bioservices Third Quarter Fiscal 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, this conference call may be recorded.
I would now like to hand the conference over to Tim Brons of Avid's Investors Relations Group. Please go ahead.
Tim Brons
Thank you. Good afternoon and thank you for joining us. On today's call, we have Nick Green, President and CEO; Dan Hart, Chief Financial Officer; and Matt Kwietniak, Avid’s Chief Commercial Officer. Today, we will be providing an overview of Avid Bioservices contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended January 31, 2024. After our prepared remarks, we will welcome your questions.
Before we begin, I'd like to caution that comments made during this conference call today, April 29, 2024, will contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, concerning the current belief of the company, which involves a number of assumptions, risks and uncertainties. Actual results could differ from these statements and the company undertakes no obligation to revise or update any statement made today. I encourage you to review all the company's filings with the Securities and Exchange Commission concerning these and other matters. Our earnings press release includes discussion of certain non-GAAP information. You can find our earnings press release, including relevant non-GAAP reconciliations on our corporate website at avidbio.com....
Avid Bioservices, Inc. (CDMO) Q3 2024 Earnings Call Transcript